Daniel Reuland MD, MPH

Dr. Reuland’s primary research focus is on applied translational research studying how to improve the delivery of guideline-recommended cancer screening in health care and public health practice. In recent years he has led a study funded by the National Cancer Institute’s Cancer Moonshot program testing a colorectal cancer screening intervention in North Carolina Federally Qualified Health Centers. He also participates in multi-disciplinary efforts to study, develop, and evaluate policies and processes for implementing lung cancer screening in health systems, including UNC Health. Dr. Reuland is the Director of the Carolina Cancer Screening Initiative (CCSI) within the UNC Lineberger Comprehensive Cancer Center. Supported by the University Cancer Research Fund as well as external research grants, CCSI infrastructure facilitates applied research in partnership with academic, government, and community health partners that can lead to improved cancer screening in North Carolina. He also serves as a faculty member in the Community Engagement Core at the North Carolina Translational and Clinical Sciences (NC TraCS) Institute, where his work has included promoting the inclusion of Spanish-speaking Latinx populations in translational health research. Dr. Reuland also holds an adjunct faculty appointment in the UNC Gillings School of Global Public Health, Department of Health Policy and Management, as well as center appointments/ memberships in the Lineberger Comprehensive Cancer Care Center – Cancer Prevention and Control Program, Cecil G. Sheps Center for Health Services Research, and the NC TraCS Institute.